Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors [NA]
Completed trial comparing standard neuronavigation to intraoperative MRI for neurosurgical treatment of malignant brain tumors, including gl…
-
FDA approval · 2015-04-02FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for TEMODAR (temozolomide) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme [Phase 3]
Phase 3 trial comparing short-course versus standard-course radiotherapy for elderly and/or frail patients with glioblastoma multiforme has …
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating Zactima with Temodar during radiation for newly diagnosed stage IV brain tumors (glioblastoma multifor…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Phase I/II Study of the Photon Radiosurgery System [Phase 1, Phase 2]
Clinical trial update indicating completion of Phase I/II study of the Photon Radiosurgery System for recurrent brain tumors, including glio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-05FDA Approved: TEMOZOLOMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application to authorize a generic version of temozolomide.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
This Phase 1 trial update reports on the combination of tipifarnib, radiation therapy, and temozolomide in adults with newly diagnosed gliob…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma [Phase 2]
This is a Phase 2 trial update for AR-67 in adults with recurrent glioblastoma multiforme or gliosarcoma. The current status of the study is…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients [EARLY_Phase 1]
An early-phase pilot study evaluating nutrition status in patients with glioblastoma multiforme; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial evaluating Gliadel wafers with radiation therapy and temozolomide, with bevacizumab, for newly diagnosed glioblastoma multifor…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 clinical trial update of ICT-107 immunotherapy in glioblastoma multiforme; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection [Phase 2]
Phase 2 trial update assessing the efficacy and safety of autologous dendritic cell vaccination in glioblastoma multiforme after complete su…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM [Phase 2]
A Phase 2 clinical trial evaluating radiation therapy and temozolomide followed by temozolomide and Poly ICLC in newly diagnosed glioblastom…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating Gliadel Wafer in combination with O6-Benzylguanine for recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma [Phase 2]
Phase 2 trial evaluating temozolomide with O6-benzylguanine in temozolomide-resistant malignant glioma has completed.
-
FDA approval · 2014-03-20FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Temodar (temozolomide) by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma [Phase 2]
A phase 2 trial evaluating chemotherapy and radiation therapy after surgery in children with newly diagnosed astrocytoma, glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial update reports results for a vaccine therapy in patients with newly diagnosed glioblastoma multiforme; results were…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Phase 2]
Phase 2 trial of radiation therapy followed by bleomycin in adults with newly diagnosed supratentorial glioblastoma multiforme (brain tumor)…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
This clinical trial update covers Phase 1 and Phase 2 evaluations of lapatinib in patients with recurrent glioblastoma multiforme. The study…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating radiation therapy in combination with temozolomide and irinotecan for newly diagnosed glioblastoma multifo…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Biological Therapy in Treating Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial update evaluating a biological therapy for glioblastoma multiforme has been completed. The study status is reported a…
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
An update on a Phase 1/Phase 2 combination chemotherapy trial for patients with recurrent glioblastoma multiforme, sponsored by Atlantic Hea…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A clinical trial update describing a study of radiation therapy combined with hyperbaric oxygen for newly diagnosed Glioblastoma multiforme …
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial update evaluating Carmustine for progressive or recurrent glioblastoma multiforme.